In-silico trials with human modelling and simulation for guiding optimal stratification of atrial fibrillation patients to catheter ablation and pharmacological therapy
<p>Atrial fibrillation (AF) is the most prevalent sustained arrhythmia, affecting over 43 million people worldwide and one in 45 people in the UK. The modest efficacy of currently available therapies adds to the nature of the problem. Antiarrhythmic medication and catheter ablation are the two...
Κύριος συγγραφέας: | Dasí i Martinez, A |
---|---|
Άλλοι συγγραφείς: | Bueno Orovio, A |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2023
|
Θέματα: |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
In-silico drug trials for precision medicine in atrial fibrillation: From ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria
ανά: Albert Dasí, κ.ά.
Έκδοση: (2022-09-01) -
Virtual In-Silico Modeling Guided Catheter Ablation Predicts Effective Linear Ablation Lesion Set for Longstanding Persistent Atrial Fibrillation: Multicenter Prospective Randomized Study
ανά: Jaemin Shim, κ.ά.
Έκδοση: (2017-10-01) -
Commentary: Virtual In-Silico Modeling Guided Catheter Ablation Predicts Effective Linear Ablation Lesion Set for Longstanding Persistent Atrial Fibrillation: Multicenter Prospective Randomized Study
ανά: Axel Loewe, κ.ά.
Έκδοση: (2017-12-01) -
Catheter Ablation for Atrial Fibrillation
ανά: Andre J. Gauri, κ.ά.
Έκδοση: (2003-10-01) -
Editorial: Atrial fibrillation: insights on mechanisms, mapping and catheter ablation
ανά: Sergio Conti, κ.ά.
Έκδοση: (2023-09-01)